HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Syndromic X-linked intellectual disability type 7 — Clinical Guidelines

Overview

Syndromic X-linked intellectual disability type 7 encompasses a spectrum of clinical features often associated with mutations in the MED12 gene, including intellectual disability, distinctive facial features, skeletal anomalies, and additional systemic involvement such as Hirschsprung disease 1.

Diagnosis

Key Diagnostic Criteria:

- Intellectual disability - Facial dysmorphisms (e.g., blepharophimosis) - Skeletal anomalies (e.g., short humeri) - Additional features like Hirschsprung disease 1

Recommended Tests:

- Genetic sequencing focusing on MED12 gene 1 - Subtelomeric FISH analysis in cases with atypical presentations or complex chromosomal abnormalities 2

Management

First-Line Treatments:

- Early intervention programs for developmental support 1 - Management of Hirschsprung disease with surgical intervention if present 1

Adjunctive Treatments:

- Pharmacological management of epilepsy with antiepileptic drugs (specific dosing not detailed in abstracts) 3 - Ophthalmic care for severe hypermetropia 2

Special Populations

Pediatrics:

- Early identification and intervention crucial for developmental outcomes 1

Comorbidities:

- Epilepsy management tailored to individual patient needs 3

Key Recommendations

Perform genetic sequencing targeting MED12 mutations in patients presenting with intellectual disability, facial dysmorphisms, and skeletal anomalies (Evidence: Moderate 1)

Consider subtelomeric FISH analysis in cases with atypical presentations or complex chromosomal abnormalities to explore alternative genetic causes (Evidence: Weak 2)

Implement comprehensive early intervention programs to support developmental milestones in affected children (Evidence: Expert opinion 1)

References

1 Isidor B, Lefebvre T, Le Vaillant C, Caillaud G, Faivre L, Jossic F et al.. Blepharophimosis, short humeri, developmental delay and hirschsprung disease: expanding the phenotypic spectrum of MED12 mutations. American journal of medical genetics. Part A 2014. link 2 Ferrero GB, Belligni E, Sorasio L, Delmonaco AG, Oggero R, Faravelli F et al.. Phenotype resembling Donnai-Barrow syndrome in a patient with 9qter;16qter unbalanced translocation. American journal of medical genetics. Part A 2006. link 3 Richieri-Costa A, Frota-Pessoa O. Atrichia, abnormal EEG, epilepsy and mental retardation in two sisters. Human heredity 1979. link

Syndromic X-linked intellectual disability type 7